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ABSTRACT Chlamydiae are obligate intracellular bacteria comprising well-known
human pathogens and ubiquitous symbionts of protists, which are characterized by
a unique developmental cycle. Here we comprehensively analyzed gene expression
dynamics of Protochlamydia amoebophila during infection of its Acanthamoeba host
by RNA sequencing. This revealed a highly dynamic transcriptional landscape, where
major transcriptional shifts are conserved among chlamydial symbionts and patho-
gens. Our data served to propose a time-resolved model for type III protein secre-
tion during the developmental cycle, and we provide evidence for a biphasic metab-
olism of P. amoebophila during infection, which involves energy parasitism and
amino acids as the carbon source during initial stages and a postreplicative switch
to endogenous glucose-based ATP production. This ﬁts well with major transcrip-
tional changes in the amoeba host, where upregulation of complex sugar break-
down precedes the P. amoebophila metabolic switch. The biphasic chlamydial me-
tabolism represents a unique adaptation to exploit eukaryotic host cells, which likely
contributed to the evolutionary success of this group of microbes.
IMPORTANCE Chlamydiae are known as major bacterial pathogens of humans, caus-
ing the ancient disease trachoma, but they are also frequently found in the environ-
ment where they infect ubiquitous protists such as amoebae. All known chlamydiae
require a eukaryotic host cell to thrive. Using the environmental chlamydia Pro-
tochlamydia amoebophila within its natural host, Acanthamoeba castellanii, we inves-
tigated gene expression dynamics in vivo and throughout the complete chlamydial
developmental cycle for the ﬁrst time. This allowed us to infer how a major viru-
lence mechanism, the type III secretion system, is regulated and employed, and we
show that the physiology of chlamydiae undergoes a complete shift regarding car-
bon metabolism and energy generation. This study provides comprehensive insights
into the infection strategy of chlamydiae and reveals a unique adaptation to life
within a eukaryotic host cell.
KEYWORDS Protochlamydia, RNA-seq, chlamydia, developmental cycle, gene
expression, host-microbe interaction, metabolism, symbiont, type III secretion system
Chlamydiae represent an ancient group of obligate intracellular bacteria (1). Hun-dreds of millions of years of evolution in association with eukaryotic host cells gave
rise to successful pathogens of humans and diverse, globally distributed environmental
chlamydiae associated with protists and animals (2–4). The human pathogen Chlamydia
trachomatis (family Chlamydiaceae) is a frequent cause of sexually transmitted diseases
and sight-threatening infections, affecting more than 180 million people each year (5,
6). While the chlamydiae are currently represented by a limited number of families,
molecular evidence suggests the existence of a tremendous diversity in diverse habitats
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Transcriptional landscape of the
chlamydial symbiont Protochlamydia
amoebophila reveals unique bi-phasic
metabolism during infection.
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(250 unexplored families), including potential new emerging pathogens (3, 7–11).
Despite this diversity, all chlamydiae undergo a biphasic developmental cycle (2, 12). A
detailed knowledge of this deﬁning feature is the key to understanding the biology,
evolution, and host interactions of this unique group of microbes.
The chlamydial developmental cycle consists of two morphologically and physio-
logically distinct stages termed elementary bodies (EBs) and reticulate bodies (RBs) (2,
12). Infection of eukaryotic host cells occurs at the EB stage. After host cell entry, EBs
differentiate quickly into replicating RBs, which reside within a cytoplasmic vacuole
called an inclusion, and undergo several rounds of cell division. RBs asynchronously
convert back to EBs, which are subsequently released into the extracellular environ-
ment by host cell lysis or nonlytic extrusion (12, 13). The developmental cycle has
mainly been studied for chlamydial pathogens, such as C. trachomatis and C. pneu-
moniae. Although there are slight variations between organisms, the cycle is well
conserved among all known chlamydiae and likely has evolved before their diversiﬁ-
cation (1, 14–18).
DNA microarray and quantitative PCR studies have been instrumental in elucidating
the molecular basis of the developmental cycle of C. trachomatis and C. pneumoniae,
which found that infection and differentiation processes are accompanied by marked
temporal changes of gene expression (19–24). The recent sequencing of entire tran-
scriptomes (RNA-seq) using next-generation sequencing platforms improved the de-
tection of early chlamydial genes (25), facilitated the identiﬁcation of transcription start
sites, and led to the discovery of novel transcripts (26, 27). However, this powerful
technology has not yet been applied to study the chlamydial developmental cycle over
the entire course of infection. In addition, although this method has the potential to
interrogate microbe and host transcriptomes simultaneously (28), technical challenges
have hampered its application for the analysis of chlamydiae, with only a single study
available so far (25).
Protochlamydia amoebophila (hereafter referred to as Protochlamydia; a member of
the family Parachlamydiaceae) is a well-studied symbiont (29–31). Of key importance,
Protochlamydia in its natural Acanthamoeba host represents an in vivo infection model
to study the dynamics of host-microbe interactions, and the model does not rely on the
use of immortalized cell lines. Studying these environmental counterparts of the
Chlamydiaceae has led to a number of discoveries with important implications for our
understanding of the basic biology of all chlamydiae, including the discovery of
peptidoglycan and metabolic activity of EBs (18, 32–37). Yet, a detailed analysis of the
Protochlamydia developmental cycle and the underlying gene expression dynamics has
thus far been strikingly lacking.
In this study, we describe the course of the infection and investigate the transcrip-
tome of Protochlamydia and its amoeba host at key time points by RNA-seq. Highlight-
ing conserved chlamydial and unique protochlamydial developmental events we aimed
at understanding general chlamydial biology, including the role of protein secretion
and the metabolic strategy accompanying the transitions between developmental
stages. Our analyses revealed the conservation of a pronounced temporal gene ex-
pression proﬁle during the developmental cycle among amoeba-associated chlamydiae
and chlamydial pathogens and support a model in which a major shift in the metab-
olism of Protochlamydia—from energy parasitism to endogenous energy production—
occurs during differentiation.
RESULTS AND DISCUSSION
Three main temporal classes of gene expression. We investigated the develop-
mental cycle of the amoeba endosymbiont Protochlamydia by monitoring the course of
infection using ﬂuorescence in situ hybridization, 4=,6=-diamidino-2-phenylindole (DAPI)
staining, and transmission electron microscopy, and by quantifying the production of
infectious EBs (Fig. 1). In summary, Protochlamydia in its Acanthamoeba host exhibits
the characteristic chlamydial developmental cycle (see Text S1 in the supplemental
material for details). Completion of the cycle takes 96 h, slightly longer than what has
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been reported for chlamydiae infecting humans and animals (20, 21). It is, however,
shorter than the 6 to 15 days observed for other chlamydiae (14, 17, 38).
For RNA sequencing, we selected four time points that mark crucial developmental
events during infection: 2 h postinfection (hpi) representing the start of EB-to-RB
FIG 1 Developmental cycle of Protochlamydia amoebophila. (A) Fluorescence in situ hybridization in combination with
DAPI staining was used to differentiate between RBs (pink) and EBs (blue). At 2 h postinfection EBs clearly dominate, but
a few cells have already started to convert to RBs (white arrowheads). Exclusively RBs were detected at 48 hpi. The ﬁrst
EBs (white arrows) were seen at 72 hpi. The inset for the 24 hpi image is an enlargement of dividing RBs (to enhance
clarity, the DAPI signal is shown in white). Dotted white lines indicate the outlines of amoeba host cells. If not indicated
otherwise, all bars represent 10 m. (B) The course of EB production and release was quantiﬁed by collecting intra- and
extracellular bacteria, respectively, at indicated time points, and subsequent reinfection of fresh amoebae. The ﬁrst
intracellular EBs were present at 72 hpi, the ﬁrst release of EBs was observed at 96 hpi. Values that are signiﬁcantly
different (P  0.05) at the various time points by one-way analysis of variance (ANOVA) and Tukey’s posttest are
indicated by an asterisk (n  3). Prop., proportion. (C) Transmission electron micrographs visualizing developmental
events at the ultrastructural level. Black arrows point to bacterial cells in overview images. Black arrowheads indicate
vesicles that were observed in the inclusion lumen from 24 hpi on. Bars  1 m.
Transcriptional Landscape of a Chlamydial Symbiont
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transition, 48 hpi as the peak of RB activity, 96 hpi covering secondary differentiation,
and released EBs (Fig. 1 and Text S1). Despite different sequencing read numbers that
could be mapped to the Protochlamydia genome at each time point (Table S1), the
sequencing depths of all samples and the similarities between biological replicates
were sufﬁcient (Fig. S1 and Text S1) to identify 737 protein-coding genes that were
differentially expressed (DE) at least once during the developmental cycle (correspond-
ing to 51% of all genes with expression data) (Fig. 2). All other expressed genes were
considered constitutively expressed genes (Fig. S2A). Hierarchical clustering of DE
genes by expression proﬁles revealed three main temporal classes of gene expression
(Fig. 2 and Data Set S1), whose expression proﬁles are broadly reﬂected in the EB
proteome determined previously (39) (Fig. 2). Importantly, these three main temporal
groups (termed early, mid, and late genes) correspond well with those found in
microarray studies of Chlamydiaceae (23). Therefore, the pronounced transcriptional
switches accompanying EB-to-RB transition and intracellular establishment, RB activity,
and RB-to-EB transition are conserved among amoeba-associated chlamydiae and the
Chlamydiaceae and represent a hallmark of all chlamydiae. However, given the propor-
tionally larger number of differentially regulated genes upon entry and early develop-
mental events we found for Protochlamydia (Fig. S3 and Text S1), amoeba-associated
chlamydiae require a higher degree of adjustment when transitioning to the intracel-
lular environment.
Temporal partitioning of biological processes during development. The three
main temporal gene expression classes can be further subdivided into ﬁve distinct gene
expression patterns termed here early I, early II, mid, late I, and late II (Fig. 2). The
analysis of these gene sets provides detailed insights into the course of biological
processes during chlamydial development.
FIG 2 Temporal classes of gene expression during the Protochlamydia developmental cycle. A total of 797 genes were detected as
differentially expressed; tRNA genes (20 genes), rRNA genes (2 genes), and genes detected only in a single replicate (38 genes) were
excluded from further analysis. Clustering identiﬁed three main temporal classes of gene sets (colored bars to the left of the heatmap)
that could be further divided into ﬁve large subclasses (colored bars to the right of the heatmap). The largest group of genes was most
highly expressed early (n  304), whereas the expression of the smallest group of genes peaked at midcycle when only RBs were present
(n  161). The third main gene cluster generally showed highest expression at the end of the cycle and the extracellular stage (n  273;
see Data Set S1 in the supplemental material). Gene products detected in the EB proteome in a previous study (n 231) (39) are indicated
in the bar plot next to the heatmap. To illustrate the course of gene expression for each subcluster, the expression values (log2 RPKM
plotted on the y axis) were averaged per time point (x axis) and visualized as line plots (error bars indicate standard deviations). Selected
gene names are shown for each of the temporal clusters. RPKM, reads per kilobase per million; hpi, h postinfection; extracell., extracellular;
PG, peptidoglycan synthesis; T3SS, type III secretion system.
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Early I genes (n  74) are highly expressed at 2 hpi and then strongly downregu-
lated at midcycle. They remain at a lower expression level until late in the development,
but transcripts are notably abundant in extracellular EBs (Fig. 2). Some of the genes
referred to as “tardy” genes in a previous C. pneumoniae microarray study (20) follow a
similar expression pattern, yet this transcriptional proﬁle is strikingly pronounced in
Protochlamydia. mRNA has been detected in EBs (20, 22, 26, 27, 40), which would be
consistent with transcriptional activity, but EBs are generally considered transcription-
ally silent (23). mRNA detected in EBs could thus represent “carryover” mRNA (19), for
which it has been unclear whether it is actually used as the templates for translation
(23). Here we propose that these transcripts are preserved in EBs to be readily available
and functional during initial infection events. Consistent with this view, we ﬁnd many
genes encoding structural type III secretion proteins in this temporal class, as well as a
number of predicted type III effectors (Fig. 2 and 3). Among those is a Protochlamydia-
speciﬁc orthologue of the major enterobacterial virulence factor IpgD, which in Shigella
facilitates host cell entry (41) and might be functionally similar to the Chlamydiaceae
Tarp (42, 43). Taken together, the conspicuous expression pattern of the early I gene set
points at a function in invasion of the amoeba host.
A second set of early genes termed early II (n  226) is upregulated at 2 hpi,
subsequently downregulated, and—in contrast to early I genes—remains at a lower
expression level for the rest of the cycle, including the EB stage (Fig. 2). These genes
thus likely function mainly in EB-to-RB conversion and are important for establishing
the intracellular niche. Consistently, this temporal class contains genes that in C. tra-
chomatis follow a similar expression pattern (e.g., the chlamydia-speciﬁc inclusion
membrane proteins and the transcriptional repressor of known late genes Euo) (19, 22,
23). This temporal class, however, was dominated in Protochlamydia by a large number
of putative eukaryotic-like effectors with many exhibiting Sel1-like repeat domains or
belonging to the recently identiﬁed large gene families PEX1 and PEX2 encoding
proteins potentially involved in modiﬁcation of host ubiquitination processes (Fig. 3
and Fig. S4) (33). Together, this indicates that while conserved chlamydial processes are
at work during early niche establishment and RB-to-EB differentiation, Protochlamydia
also employs a set of species-speciﬁc effector proteins during this stage.
The midcycle gene set comprises genes sharply upregulated at 48 hpi, when mainly
RBs are present (Fig. 1). Transcripts for many of these genes were also detected at later
stages at similar expression levels (Fig. 2) when the developmental cycle becomes more
asynchronous. At this peak of RB activity, cellular processes like translation and meta-
bolic activity (lipid and amino acid transport and metabolism) are most prominent
(Fig. 3). Consistent with high metabolic activity, a number of genes responsible for cell
division and peptidoglycan synthesis were upregulated, or by trend increased at
midcycle (Fig. S2B). Analyzing the distribution of conserved and species-speciﬁc genes
across the observed temporal gene expression classes revealed that the midcycle gene
set was dominated by genes present in all chlamydiae, thereby conﬁrming the role of
chlamydial core genes in RB metabolism and proliferation (Fig. S5 and Text S1).
We found two subsets of late genes that are both characterized by an increased
expression at the end of the cycle at 96 hpi and by generally high transcript levels at
the EB stage (Fig. 2). Expression of late I genes (n  105) already begins to increase at
midcycle; the upregulation of late II genes (n 168) is slightly delayed. These genes are
thus involved in RB-to-EB transition, EB function, and EB maintenance.
Late I genes are enriched in genes involved in biosynthesis of porphyrins such as the
cofactor heme required for the production of cytochromes (Fig. 3). This temporal class
also includes genes involved in glucose and glycogen metabolism, such as glucokinase
(glcK) and glycogen synthase (glgA), suggesting that glucose-based energy production
is important at this stage. This trend is supported by the functions of late II genes, which
are enriched in genes responsible for energy generation, including the electron trans-
port chain for ATP synthesis (Fig. 3). Consistent with the presence of type III secretion
systems on chlamydial EBs, we ﬁnd many genes encoding structural proteins and
Transcriptional Landscape of a Chlamydial Symbiont
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known (CopB) and predicted effectors among the late I and late II gene sets (Fig. 3) and
(Fig. S4).
A temporal model for chlamydial type III secretion. The type III secretion system
is an evolutionarily well conserved major virulence factor that was present in the last
common ancestor of all known chlamydiae (1, 44, 45). Here we observed that genes
involved in type III secretion, including structural components, chaperones, and effec-
tors, belong to all ﬁve temporal gene sets and show strikingly different expression
proﬁles (Fig. S4). While the basal apparatus and most components of the C-ring
complex required for structural integrity and secretion activity (e.g., sctD, sctC) are
expressed mid to late during RB/EB transition, notably lacking at this stage is a
pronounced expression of the gene encoding the needle protein SctF. In fact, the
transcript levels of the needle protein, the translocon CopB, most known chaperones,
most putative effectors, as well as additional inner membrane components and the
ATPase increase only later during maturation of EBs but then continue to be highly
expressed early during infection (Fig. S4).
Our gene expression-centric view of type III secretion thus suggests a stepwise
assembly of the Protochlamydia type III secretion apparatus, which is consistent with
knowledge about type III secretion system assembly in other bacteria (46) and models
for Chlamydiaceae proposed earlier (45). Our time-resolved model for the role of type
III secretion during the developmental cycle includes three major steps (Fig. 4). The ﬁrst
step is the formation of the main parts of novel type III secretion machineries mainly
during RB-to-EB differentiation; because of the lack of a pronounced expression of the
needle protein and other factors prior to this stage, we propose that type III secretion
machineries are mostly incomplete at midcycle and therefore, secretion is less promi-
nent when RBs likely devote most of their resources to proliferation (Fig. 3). At the tail
end of RB-to-EB differentiation, SctF is upregulated, and most secretion machineries are
then fully equipped. Thus, the second step is marked by functional type III secretion
systems that are present on extracellular EBs and can be employed for host cell
invasion. The third step is characterized by the peak of type III secretion activity
occurring in early RBs, where we observed all structural components, including the
needle protein to be continuously highly expressed. Importantly, the major role of type
III secretion during early development is also well supported by the largest number of
(putative) effectors upregulated at this stage (Fig. 4 and Fig. S4).
FIG 3 Enrichment of functional categories by temporal class. The overrepresentation of functional categories among
genes assigned to temporal classes provides evidence for stage-speciﬁc activities during the Protochlamydia develop-
mental cycle. Only functional categories that were signiﬁcantly enriched with a false-discovery rate (FDR) of 0.05 are
shown here; the color code indicates the degree of signiﬁcance (dark red indicates highly signiﬁcant). The signiﬁcant
enrichment of putatively type III secreted gene products was tested using Fisher’s exact test, and only P values of 0.05
are shown. cat, category.
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It is well-known that type III secretion genes of bacterial pathogens are temporally
regulated (47). Moreover, our model is consistent with gene expression data for the
Chlamydiaceae, which indicate that the large majority of type III secretion component
genes are temporally regulated and increasingly expressed from midcycle toward the
end (19–21, 48, 49). The model is also supported by proteomic analyses of Protochla-
mydia and C. trachomatis EBs and RBs in which most type III secretion system compo-
nents were identiﬁed on prereplicative RBs (50) and EBs (39, 51). The model is also
generally in agreement with recent (cryo-)electron tomography analyses of Protochla-
mydia and C. trachomatis, demonstrating the presence of type III secretion systems on
host-free EBs (52–54) and late RBs (55). Finally, our interpretation that type III secretion
systems are more abundant on early RBs compared to EBs matches electron micros-
copy data for Chlamydia psittaci (56). The model is, however, not consistent with the
apparent absence of the type III secretion machinery on C. trachomatis EBs noted
immediately after host entry in a cryo-electron tomography-based study (54), which
would imply that type III secretion is not required at this stage. The latter scenario is
difﬁcult to reconcile with the general notion that effector secretion is essential during
early development (45, 57). We thus propose that type III secretion is active to facilitate
invasion by EBs, but based on the pronounced early gene expression of type III
secretion components and effectors—observed here for the ﬁrst time—is substantially
enhanced during establishment of the replicative niche by early RBs (Fig. 4).
Biphasic metabolism of Protochlamydia. A number of previous observations
provide evidence for developmental stage-speciﬁc differences of the chlamydial me-
tabolism (reviewed in reference 58). Our comprehensive transcriptomic data set allows
us to dissect the activity of individual pathways and metabolic modules during the
Protochlamydia developmental cycle. As a result, we are able to propose a detailed
model for the modulation of chlamydial physiology during infection and extracellular
survival.
FIG 4 Course of Protochlamydia type III secretion system activity during the developmental cycle. This model is based on the observation
that structural components of the type III secretion system and its (putative) effectors are expressed at different time points during the
developmental cycle (Fig. S4). This suggests a scenario in which novel, fully assembled, and thus functional secretion systems occur only
late in the developmental cycle, and type III secretion reaches its full capacity and highest activity during early stages of the infection. The
indicated polarity of the active type III secretion system has been shown for C. trachomatis (54), but it is unclear whether this is also true
for P. amoebophila, as the symbionts reside within single-cell inclusions. The color code for type III secretion components and effectors
(nomenclature according to Hueck [105]) refers to the respective temporal gene expression classes (Fig. 2 and Fig. S4). Circles inside the
cells represent chaperones. Differentially expressed components/effectors are labeled with asterisks; PEX1 and PEX2 refer to members of
the expanded effector gene families in Protochlamydia (33); pc0309 is an ortholog of the putative chaperone encoded by CT274 (106). inc,
inclusion membrane; hcm, host cell membrane; im, inner membrane; om, outer membrane.
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Stage-speciﬁc energy sources. Chlamydiae are well-known energy parasites facil-
itated by nucleotide transport proteins, which import host-derived ATP in exchange for
ADP (59, 60). Yet, they also harbor the genetic potential to synthesize ATP via oxidative
phosphorylation. Our gene expression analysis, however, revealed that in Protochla-
mydia, genes involved in carbon and energy metabolism show a low transcription level
at midcycle and are induced only late during development (Fig. 5). At the replicative
stage, the import of host-derived ATP is thus likely the most important energy source.
The ATP/ADP translocase (ntt1) is constitutively expressed at an exceptionally high level
(among the top 1% of all expressed genes), and although it was not detected as
signiﬁcantly differentially expressed, its transcription proﬁle clearly peaks at midcycle
(Fig. 5). The same trend has been observed for C. trachomatis and C. pneumoniae (19,
20), and nucleotide transport proteins were most abundant in C. trachomatis RBs
compared to EBs (51). In addition, ATP but not glucose-6-phosphate stimulated de novo
protein synthesis in C. trachomatis RBs in a chemically deﬁned axenic medium (61).
Because late genes were enriched in respiratory chain genes (Fig. 3), we compiled
detailed gene expression heatmaps for all genes known to be part of the chlamydial
carbon and energy metabolism pathways (Fig. 5). Strikingly, we also found genes
involved in glycolysis, the pentose phosphate pathway, and the tricarboxylic acid (TCA)
cycle to be generally upregulated only late during development. In agreement, we
FIG 5 Expression maps of selected metabolic pathways of Protochlamydia. A pronounced expression of the ATP/ADP translocase (ntt1) at midcycle and an
early-to-mid activity of genes involved in amino acid breakdown to pyruvate is observed, whereas pathways involved in central carbon metabolism and energy
generation were generally only upregulated at later stages (with the ATPases indicated by purple boxes being notable exceptions). This suggests that a major
metabolic shift occurs during the developmental cycle and provides evidence for a stage-speciﬁc metabolism. All genes marked with an asterisk were detected
to be signiﬁcantly differentially expressed. RPKM, reads per kilobase per million; hpi, h postinfection; extracell., extracellular.
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observed a pronounced upregulation of genes responsible for glutamate and aspartate
breakdown (gdhB, glutamate dehydrogenase; aspC, aspartate aminotransferase; Fig. 5),
whose end products could fuel the TCA cycle.
A notable exception are the V-type and the F-type ATPases whose expression is
induced at midcycle, a trend which was also seen for the respective C. trachomatis
proteins (51). In the absence of other main components of the respiratory chain at this
stage, the ATPases likely engage in hydrolysis of ATP (rather than ATP synthesis) and
thus act as proton/sodium pumps maintaining the membrane potential—a function
well-known for both types of ATPases and proposed for the ATPase in C. psittaci RBs
(62–64). In Protochlamydia, the ATPases continue to be expressed at later stages, when
all components of the oxidative phosphorylation pathway are in place. The proton/
sodium gradient can then be generated by the other complexes of the respiratory
chain, and the ATPases would function in ATP synthesis.
This model ﬁts well with ﬁndings for C. trachomatis, where proteins involved in the
endogenous energy metabolism were detected only in EBs, not in RBs (65), or were
found to be more abundant in EBs (51). Moreover, glucose 6-phosphate but not ATP
stimulated de novo protein synthesis in host-free C. trachomatis EBs, and ATP genera-
tion was observed at this stage (61). Furthermore, we have previously shown that
C. trachomatis and Protochlamydia EBs require glucose 6-phosphate or glucose, respec-
tively, for maintenance of infectivity during extracellular survival (35). In conclusion, the
gene expression data presented here provide compelling evidence that a stage-speciﬁc
energy metabolism indeed occurs in vivo and that it is well conserved among known
chlamydiae.
Amino acids and pyruvate as main carbon source during replication. Another
consequence of the observed expression of genes involved in breakdown of glucose
predominantly at the postreplicative stage is that glucose cannot represent the major
carbon source at the RB stage. In fact, chlamydiae acquire the majority of cell building
blocks such as amino acids, nucleotides, and certain lipids from the host cell (66).
Transport proteins required for the uptake of those compounds exist, and most of the
24 known amino acid transporters of Protochlamydia are expressed early and midcycle,
providing all the substrates required for protein synthesis in RBs (Fig. 5). The impor-
tance of host-derived amino acids for chlamydial protein synthesis is well supported by
a recent isotopologue proﬁling study of C. trachomatis (67). While no external carbon
source might thus be required for protein, DNA, and RNA synthesis, chlamydiae clearly
need carbon to synthesize branched-chain fatty acids for the generation of phospho-
lipids (68). Consistent with this notion, lipid metabolism was induced at the replicative
stage in Protochlamydia (Fig. 3). This includes the pyruvate dehydrogenase genes
(pdhABC), which were upregulated early and at midcycle and catalyze the conversion of
pyruvate to acetyl coenzyme A (acetyl-CoA), the precursor of fatty acid biosynthesis
(Fig. 5). The pyruvate required for this step could be imported directly from the host as
suggested for C. psittaci (69), although no pyruvate transporter has yet been identiﬁed
in Protochlamydia or Chlamydiaceae. Pyruvate cannot be generated from host-derived
nucleotides or host lipids, as Protochlamydia lacks the genetic repertoire for breakdown
of those compounds. However, genes encoding components involved in degradation
of amino acids are present and were indeed most highly expressed early (sdaA, L-serine
dehydratase) and at midcycle (tdh, L-threonine 3-dehydrogenase; ald, alanine dehydro-
genase; gcvT, T protein of the glycine cleavage complex; Fig. 5). These enzymes
catabolize alanine, threonine, glycine, and serine to pyruvate, which may then serve as
the substrate for branched-chain fatty acid synthesis. The increased number of gene
copies encoding a speciﬁc transporter for alanine (dagA) and their early and midcycle
expression further support a model in which amino acids provide the carbon required
for fatty acid biosynthesis in Protochlamydia RBs (Fig. 6).
Metabolism of EBs. Many of the late genes involved in carbon and energy
metabolism are still highly expressed at the EB stage in Protochlamydia. Remarkably,
this is also the case for genes involved in transcription and protein synthesis. This
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includes the RNA polymerase, amino acid transporters, and many translation-related
genes (Fig. 5 and Fig. S2A). Our transcriptome data thus support a number of early
observations and recent ﬁndings suggesting that chlamydial EBs are not metabolically
inert but maintain a limited metabolism during host-free survival (35, 36, 58, 61).
Biphasic versus bipartite metabolism. In summary, transcriptional dynamics dur-
ing the Protochlamydia developmental cycle provide compelling evidence for a bipha-
sic metabolism with stage-speciﬁc carbon and energy sources (Fig. 6). This is well
supported by a number of earlier ﬁndings, suggesting that a biphasic metabolism is
generally conserved among known chlamydiae (51, 58, 61).
In addition to these stage-speciﬁc differences in physiology, a recent study dem-
onstrated cosubstrate usage by C. trachomatis, with host amino acids required for
bacterial protein biosynthesis and glucose 6-phosphate as the carbon source for
FIG 6 Biphasic metabolism of Protochlamydia during development in Acanthamoeba castellanii. This model is based on
observed transcriptional patterns, enriched functional categories at different developmental stages (Fig. 2, 3, and 5 and
Fig. S2A), and independent experimental evidence reported previously (see text for references). Activity of metabolic
pathways as inferred from gene expression levels followed similar trends early and at midcycle, and at the two later stages,
respectively. This suggests that ATP import and an amino acid-based anabolism prevails during the EB-to-RB transition and
RB replication. Later stages are characterized by a glucose-based metabolism and a pronounced increase in the activity of
the tricarboxylic acid (TCA) cycle and oxidative (ox.) phosphorylation pathway. Nucleotide transporters (Ntt’s) are shown
in blue, and amino acid (AA) and oligopeptide transporters are shown in green. “Multi” indicates that multiple amino
acid/peptide transporters with different substrate speciﬁcities are expressed. Question marks refer to hypothetical
transporters not yet identiﬁed. Asterisks indicate an increased expression at the RB stage compared to the early time point.
“RNA” denotes transcription, whereas “DNA” indicates DNA replication. Glc-6-P, glucose 6-phosphate; PPP, pentose
phosphate pathway; glyconeog., gluconeogenesis.
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lipopolysaccharide biosynthesis (67). Termed bipartite metabolism, this efﬁcient use of
host-derived metabolites (i.e., the use of two different carbon sources) has also been
observed in Listeria monocytogenes (70) and Legionella pneumophila (71) and might
thus represent a more general adaptation of intracellular bacteria (67).
Yet, for L. pneumophila, there is also evidence for a growth phase-dependent
metabolism. Intracellular growth of L. pneumophila within A. castellanii requires amino
acids as energy source and—similarly to our model for Protochlamydia—as the carbon
source and directly for protein biosynthesis (72, 73). Although a temporal separation of
amino acid and carbohydrate usage has not yet been shown in vivo for L. pneumophila,
a pronounced transcriptional switch between replicative and transmissive phase within
A. castellanii has been reported (74). In addition, in in vitro experiments, L. pneumophila
used serine as a major carbon source for the synthesis of other amino acids and for
energy generation during all growth phases, while glucose served as the carbon source
primarily in the postreplicative phase (71, 75). A growth or developmental stage-
speciﬁc metabolism might thus not be restricted to the chlamydiae but is perhaps more
widespread among intracellular bacteria.
Transcriptional response of the Acanthamoeba host. Close to 75% of the known
A. castellanii genes (76) were detected to be expressed during infection with Protochla-
mydia (n  12,044; Data Set S1). Although the different infection rates in our experi-
ments (5 to 60%) entail capturing only a transcript mix of infected and uninfected
amoebae, we still observed pronounced temporal patterns and characteristic expres-
sion proﬁles, with 3,582 Acanthamoeba genes found to be differentially expressed.
Major transcriptional shifts occurred at 2 hpi when 1,722 genes were up- and subse-
quently downregulated and at 48 hpi when 1,747 genes were induced (Fig. S6).
Enrichment analysis of putative gene functions at the early stage of infection
indicated a strong increase in cell signaling (serine threonine kinases), transport activity
(ABC transporter of unknown speciﬁcity), translation (tRNA-related functions), and
assembly of the mitochondrial respiratory chain complex III (Table S2). These effects on
the Acanthamoeba host are consistent with the observed pronounced expression of
type III secretion effectors by Protochlamydia at this stage, interfering with diverse host
signaling pathways and possibly inducing a stress response.
When Protochlamydia is proliferating at the RB stage, the amoeba host transcrip-
tome is characterized by increased expression of genes involved in breakdown of
complex sugars (Table S2). This might account for the increased ATP demand of
replicating Protochlamydia RBs. Notably downregulated at this stage are genes func-
tioning in cell signaling (Ras proteins, serine threonine kinases), ubiquitination, trans-
lation (ribosome biogenesis), transcription (transcription factors), and replication (DNA
replication initiation) (Table S2). Together, this suggests a general downregulation of
central cellular processes due to replicating Protochlamydia, which is at the peak of its
metabolic activity at this stage.
At later stages of the infection at which Protochlamydia EBs are formed, the amoeba
transcriptome is still signiﬁcantly altered and strikingly different compared to the onset
of the infection. In particular, genes involved in cell signaling (histidine kinases, serine
threonine kinases) are enriched at 96 hpi, whereas key cellular pathways are still less
active, illustrating the fundamental impact of Protochlamydia on gene expression of its
amoeba host (Fig. S6 and Table S2).
The response of human cells upon infection with Chlamydiaceae continues to be
extensively studied (25, 77, 78), whereas studies on the impact of environmental
chlamydiae on their host cells are strikingly lacking. Our transcriptomic data provide the
ﬁrst insights into this unexplored aspect of chlamydia-host interplay.
Conclusions. Owing to their obligate intracellular lifestyle and the lack of routine
genetic methods (79), chlamydiae are—compared to many other bacterial patho-
gens—inherently difﬁcult to study. This particularly applies to environmental chlamyd-
iae, which were discovered only about 2 decades ago. The present study represents the
most comprehensive analysis of the transcriptional landscape of chlamydiae during
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infection and development thus far. We obtained detailed insights into gene expression
dynamics of Protochlamydia and present models for metabolism and the role and
assembly of the type III secretion system at different developmental stages. Our
ﬁndings revealed striking parallels to what is known about pathogenic chlamydiae and
provide a substantially novel perspective on the interplay between chlamydiae and
protist hosts. In addition, the vast majority of chlamydial organisms lie outside the
well-known human and animal pathogens, and thus the Protochlamydia model system
serves to represent this vast diversity. Environmental chlamydiae constitute invaluable
model systems to understand fundamental chlamydial biology, common themes and
differences among known chlamydiae, and to shed light on the evolution of the
intracellular lifestyle and pathogenesis in a ubiquitous bacterial phylum.
MATERIALS AND METHODS
Cell culture. Acanthamoeba castellanii Neff (ATCC 50373) with or without the symbiont Protochla-
mydia amoebophila UWE25 (ATCC PRA-7) were maintained at 20°C in PYG medium [20 g/liter proteose
peptone, 100 mM glucose, 2 g/liter yeast extract, 1 g/liter sodium citrate dihydrate, 4 mM MgSO4 · 7H2O,
1.32 mM Na2HPO4 · 2H2O, 2.5 mM KH2PO4, 0.05 mM Fe(NH4)2(SO4)2 · 6H2O; pH 6.5]. Cultures were
regularly screened by ﬂuorescence in situ hybridization and 4=,6=-diamidino-2-phenylindole (DAPI)
staining (0.1 g/ml) to exclude contamination.
Infection experiments. Protochlamydia EBs were freshly puriﬁed from amoeba cultures grown in
500-cm2 culture ﬂasks (Nalge Nunc International, Rochester, NY, USA), in which EBs had been allowed to
accumulate in the medium for 1 week. Puriﬁcation of EBs was conducted by ﬁltering culture supernatants
through 5-m and 1.2-m syringe ﬁlters (Sartorius, Göttingen, Germany) to remove residual host cells.
Bacteria were collected by centrifugation (15,550  g, 15 min, 20°C), resuspended in precooled SPG
buffer (75 g/liter sucrose, 0.52 g/liter KH2PO4, 1.53 g/liter NaHPO4 · 7H2O, 1.53 g/liter Na2HPO4 · 2H2O,
0.75 g/liter glutamic acid; pH 7.2), homogenized using a 21-gauge injection needle (B. Braun, Melsungen,
Germany), and stored overnight at 4°C in SPG buffer. For quantiﬁcation of puriﬁed EBs, cell suspensions
were ﬁltered onto a polycarbonate membrane with a pore size of 0.2 m (EMD Millipore, Billerica, MA,
USA); cells were stained with DAPI and counted using an epiﬂuorescence microscope (Axioplan 2
imaging; Carl Zeiss, Oberkochen, Germany).
Symbiont-free amoebae were harvested 3 days before infection and 6.4  107 cells per 500-cm2
culture ﬂask per time point and replicate were seeded and incubated at 20°C until infection. To optimize
infection efﬁciency, particularly at early time points, we used a multiplicity of infection (MOI) of 150 for
2 h postinfection (hpi), an MOI of 100 for 48 hpi, and an MOI of 15 for 96 hpi. Precultivated amoebae were
harvested, transferred to 50-ml Greiner tubes, and puriﬁed Protochlamydia EBs were added, followed by
repeated centrifugation (centrifuged at 130  g twice for 5 min each time and then once for 10 min at
20°C) with vortexing between the centrifugation steps. Infected amoebae were then transferred back to
the culture ﬂasks and incubated in PYG medium at 20°C for 2 h before the infection was synchronized
by gently washing the attached amoebae three times with Page’s amoebic saline (PAS) (0.12 g/liter NaCl,
0.004 g/liter MgSO4 · 7H2O, 0.004 g/liter CaCl2 · 2H2O, 0.142 g/liter Na2HPO4, 0.136 g/liter KH2PO4). PYG
medium was added to the cultures, the culture was sampled at the 2 hpi time point, and the remaining
culture ﬂasks were incubated at 20°C for 48 and 96 h. Extracellular Protochlamydia EBs were puriﬁed as
described above. All infection experiments were performed in biological triplicates. One culture of
symbiont-free amoebae was harvested when the culture was sampled at 2 hpi.
Fluorescence in situ hybridization and transmission electron microscopy. Fluorescence in situ
hybridization using a combination of two Cy3-labeled probes (Chls-0523, E25-454; Thermo Fisher
Scientiﬁc, Waltham, MA, USA) was performed as described elsewhere (35, 80, 81), and cells were stained
with DAPI for 5 min. Images were recorded with a charge-coupled-device (CCD) camera (AxioCam HRc;
Carl Zeiss) connected to an epiﬂuorescence microscope and were processed using the AxioVision 4.6.3
software package (Carl Zeiss).
For transmission electron microscopy, the culture medium was replaced with ﬁxative solution (2.5%
glutaraldehyde in 3 mM cacodylate containing 0.1 M sucrose; pH 6.5). Amoebae were ﬁxed for 1 h at
room temperature, then collected, washed three times (0.1 M cacodylate containing 0.1 M sucrose
[pH 7.2]), and mixed with one drop of 1% Biozym plaque agarose (Biozym, Hessisch Oldendorf, Germany)
in washing buffer equilibrated at 35°C. Secondary ﬁxation was conducted in 1% buffered osmium
tetroxide for 1 h on ice, followed by dehydration in ethanol and inﬁltration with low-viscosity resin (Agar
Scientiﬁc, Essex, United Kingdom). Ultrathin sections (70 nm) were cut using a Leica EM UC7 ultrami-
crotome (Leica, Wetzlar, Germany) and stained with 0.5% uranyl acetate and 3% lead citrate, and imaging
was done with a Zeiss EM 902 transmission electron microscope (Carl Zeiss).
Infectious progeny production assay. To monitor the production of infectious Protochlamydia EBs
during the developmental cycle, amoebae were infected with Protochlamydia using an MOI of 10. The
infection was synchronized by centrifugation (130 g, 15 min, 20°C) and subsequent medium exchange.
Cells were harvested at different time points postinfection, and extracellular bacteria were separated
from amoebae by low-speed centrifugation (300  g, 10 min, 4°C). The supernatant containing the
extracellular bacteria was centrifuged (20,800 g, 30 min, 4°C), the pellet was resuspended in precooled
SPG medium, and stored at 80°C until further use. The pellet containing the infected amoebae was
resuspended in precooled SPG medium and subjected to two freeze/thaw (20°C/room temperature)
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steps, followed by vortexing with glass beads (diameter of 0.75 to 1 mm; Carl Roth, Karlsruhe, Germany)
for 3 min to break up the amoebae. Amoeba cell debris and glass beads were removed by centrifugation
(300  g, 10 min, 4°C), and the supernatants containing intracellular bacteria were stored at 80°C. The
total numbers of bacteria in intra- and extracellular suspensions were determined by counting DAPI
signals as described above. The percentage of infectious Protochlamydia EBs was determined by infecting
fresh amoebae and counting bacteria (inclusions) per amoeba at 12 hpi. The infection was carried out as
described above. Bacteria were detected by indirect immunoﬂuorescence and DAPI staining after
methanol ﬁxation as described previously (82). Mean relative infectivity of each fraction (intra/extracel-
lular) per time point was expressed as the number of bacteria or amoeba/total number of bacteria (
standard error of the mean, three biological replicates).
RNA extraction and sequencing. Preliminary tests showed that RNA extraction and sequencing of
intact Protochlamydia-infected amoebae yielded an insufﬁcient number of bacterial transcripts. Thus, to
increase the coverage of the Protochlamydia transcriptome, a protocol for enrichment of bacteria prior
to RNA extraction was developed. To minimize possible changes of the transcriptomes during enrich-
ment, each sample was processed in less than 7 min, as the half-life of total mRNA from Escherichia coli
was demonstrated to be in this range (83). Infected amoebae were harvested and collected (7,600  g,
2 min, 20°C), and the pellets were resuspended in a sucrose buffer (35 mM Tris-HCl, 250 mM sucrose,
25 mM KCl, 10 mM MgCl2) supplemented with 50 g/ml rifampin in order to inhibit active transcription
during the enrichment procedure (84, 85). Amoebae were then disrupted by vortexing in the presence
of glass beads (diameter of 0.75 to 1 mm; Carl Roth) for 1 min. The suspensions were subsequently
ﬁltered through a 5-m ﬁlter, the ﬂowthrough fractions containing the bacteria were collected by
centrifugation (10,600  g, 2 min, room temperature), and the pellets were immediately resuspended in
TRIzol reagent (Thermo Fisher Scientiﬁc). Extracellular Protochlamydia EBs were pelleted (20,800  g,
2 min, room temperature), and the pellets were resuspended in sucrose buffer and subsequently treated
like the enriched bacteria.
Cells were mechanically disrupted by beat beating for 30 s at 4.5 m/s using lysing matrix A tubes and
a FastPrep-24 instrument (MP Biomedicals, Santa Ana, CA, USA). Subsequent RNA extraction was
performed according to the TRIzol guidelines. Residual DNA was digested using the Turbo DNA-free kit
(Thermo Fisher Scientiﬁc) according to the manufacturer’s instructions. DNase-treated RNA was precip-
itated with ethanol and sodium acetate and dissolved in nuclease-free water (Thermo Fisher Scientiﬁc),
and DNA contamination was controlled for via PCR targeting a short region of the bacterial 16S rRNA
gene (SigF2/R2 primers; 11) using 35 PCR cycles. rRNA was removed using the Ribo-Zero magnetic kit for
Gram-positive bacteria as recommended by the manufacturer (Illumina, San Diego, CA, USA). To enrich
for mRNA from symbiont-free amoebae, the RNA was additionally treated with Dynabeads mRNA
puriﬁcation kit (Thermo Fisher Scientiﬁc). After another round of precipitation with ethanol, rRNA
depletion and RNA quality were examined using the Experion automated electrophoresis system
(Bio-Rad Laboratories, Hercules, CA, USA). RNA fragmentation was performed at 70°C for 5 min using the
RNA fragmentation reagents from Thermo Fisher Scientiﬁc and was followed by another ethanol
precipitation. For strand-speciﬁc cDNA library preparation, the NEBNext Ultra directional RNA library prep
kit for Illumina in combination with the NEBNext multiplex oligonucleotides (New England Biolabs,
Ipswich, MA, USA) was used starting at ﬁrst-strand cDNA synthesis. Puriﬁcation and size selection steps
were done as recommended using Agencourt AMPure beads (Beckman Coulter, Brea, CA, USA). All
libraries were sequenced using an Illumina HiSeq2000 system at the Vienna Biocenter Core Facilities
(VBCF) Next-Generation Sequencing (NGS) Unit (http://www.vbcf.ac.at) with 50-bp read length.
Sequence read processing. Sequencing reads were trimmed and cleaned before mapping (see
Text S1 in the supplemental material). To map bacterial reads to the Protochlamydia genome (18), the
Burrows-Wheeler Aligner (BWA) (86) was used; amoeba reads were mapped to the A. castellanii Neff genome
(76), the rRNA genes (87–89), and the mitochondrial genome (90) using TopHat (91), both with default
settings. Only unambiguously mapped reads were kept using SAMtools (92). Strand-speciﬁc reads per
predicted gene were counted via HTSeq (93). Reads that could not be assigned to any gene but mapped to
the genome were considered transcripts of intergenic regions (IGRs) and antisense transcripts.
Gene expression analyses. Differentially expressed genes were determined between two consec-
utive time points (2 hpi to 48 hpi, 48 hpi to 96 hpi, 96 hpi to extracellular, extracellular to 2 hpi for
Protochlamydia; uninfected to 2 hpi, 2 hpi to 48 hpi, 48 hpi to 96 hpi for A. castellanii) using the R software
environment and the Bioconductor package edgeR (94–96). Genes were considered differentially ex-
pressed if their expression changed twofold with a false-discovery rate (FDR) smaller or equal 0.05, except
for detecting gene expression changes between uninfected amoebae and infected amoebae 2 hpi, when
a ﬁvefold change threshold was used because only one sample of uninfected amoebae was sequenced.
Gene expression data were further analyzed using custom R scripts, integrated R tools, and R
packages (94). To determine temporal expression patterns, sets of genes with similar expression proﬁles
were identiﬁed by hierarchical clustering of gene expression values (log2 reads per kilobase per million
[RPKM]) based on Pearson correlation distances. Obtained clusters were validated using the R package
clValid (97). Mean centered expression values were used for visualization as heatmaps using the R
package gplots (98).
To extend and improve the available Protochlamydia genome annotation by Horn et al. (18) for each
gene, we collected Pfam domains (99), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and
gene ontology (GO) term level 5 assignments using DAVID (100), COG (clusters of orthologous groups of
proteins) cluster and class assignments using MaGe (101), and type III secretion effector predictions using
Effective (102). Blast2GO (103) was used to assign GO terms to predicted proteins of A. castellanii. The
Bioconductor software package GOseq (104) and the Blast2GO enrichment analysis tool were used to test
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for statistical enrichment of functional categories (FDR  0.05) among differentially expressed genes per
time point or temporal class. To test whether predicted type III secreted proteins were signiﬁcantly
enriched in any given gene set, two-tailed Fisher’s exact tests were conducted, and P values below 0.05
were considered statistically signiﬁcant.
Availability of data. Sequences were deposited at the Gene Expression Omnibus (GEO) database
and are accessible through accession number GSE93891.
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